Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline non-responder smoking cessation trial in dual-diagnosis outpatients
ACTRN12616001355460Phase 3Terminated
- Sponsor
- The University of Auckland
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of varenicline and nicotine in nicotine dependence (3 arms), sponsored by The University of Auckland. Primary endpoint: Continuous smoking abstinence with carbon monoxide verification. Started Jul 2017; status: terminated.
02
Drugs
vareniclinenicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on ACTRN12616001355460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001355460.